Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.

Bonn, NRW Doing business as Dzne E.V.

UEI
LGCNJ34764N3
CAGE
CF608
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Other
SAM.gov registration date
Physical address
Venusberg Campus 1, 53127 Bonn, Germany
Website
dzne.de
Founded
2009
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Trustees Of Boston University Dr. Fischer will oversee experiments in his laboratory to perform and analyze long non-coding RNA-Seq experiments performed on lllumina NovaSeq. NextSeq 2000… R01AG084624 $126,217
The Washington University DOMINANTLY INHERITED ALZHEIMER NETWORK (DIAN) PERFORMANCE SITE SCOPE OF WORK Specific Aims of DIAN 1. Establish a Dominantly Inherited Alzheimer Network of… U19AG032438 $0
Trustees Of Boston University Dr. Fischer will oversee experiments in his laboratory to perform and analyze long non-coding RNA-Seq experiments performed on lllumina NextSeq 2000 and NextSeq… RF1AG078299 $177,748

Latest 3 listed here. See the rest on GovTribe.

Similar vendors

About the company

Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V. (DZNE) is a non-profit research institute focused on studying neurodegenerative diseases. According to its website, DZNE aims to understand the causes and risk factors for neurodegeneration and to develop new therapeutic and healthcare strategies.

DZNE has received federal grant funding as both a prime recipient and subrecipient to conduct research related to neurodegenerative diseases like Alzheimer's. As a subrecipient, DZNE has provided research services to measure and analyze cerebrospinal fluid and blood plasma biomarkers linked to Alzheimer's disease progression under a subaward from Washington University. This research analyzed samples and data collected through the Dominantly Inherited Alzheimer Network (DIAN) observational study and DIAN-TU therapeutic trial. DZNE has also received subawards to relate plasma tau levels to markers of neurodegeneration and clinical progression in Alzheimer's patients. As a prime recipient, DZNE conducts research on microglial activation in Alzheimer's through analysis of cerebrospinal fluid samples from the DIAN longitudinal cohort. Through both prime and sub federal awards, DZNE provides neurodegenerative disease research services involving biofluid analysis, biomarker measurement, and data analysis.

Quick answers

Is Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V. registered in SAM.gov?

Yes. Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.'s SAM.gov registration is active through June 15, 2027.

On GovTribe

See Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E.V.'s full federal record

  • Similar vendors